Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial

AIMS: Digoxin is recommended for long-term rate control in paroxysmal, persistent, and permanent atrial fibrillation (AF). While some analyses suggest an association of digoxin with a higher mortality in AF, the intrinsic nature of this association has not been examined in propensity-matched cohorts...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gheorghiade, Mihai, Fonarow, Gregg C., van Veldhuisen, Dirk J., Cleland, John G.F., Butler, Javed, Epstein, Andrew E., Patel, Kanan, Aban, Inmaculada B., Aronow, Wilbert S., Anker, Stefan D., Ahmed, Ali
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2013
Onderwerpen:
Clinical Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3659306/
https://ncbi.nlm.nih.gov/pubmed/23592708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/eht120
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items